Anti-Fibrinolytic Agents In Traumatic Haemorrhage
Journal Title: Journal of Neurological Sciences-Turkish - Year 2005, Vol 22, Issue 2
Abstract
For people at ages 5 to 45 years, trauma is second only to HIV/AIDS as a cause of death. Each year, worldwide, over three million people die as a result of trauma, many after reaching hospital. Among trauma patients who do survive to reach hospital, exsanguination is a common cause of death, accounting for nearly half of in-hospital trauma deaths. Central nervous system injury and multi-organ failure account for most of the remainder, both of which can be exacerbated by severe bleeding. Systemic anti-fibrinolytic agents are widely used in major surgery to prevent fibrinolysis and thus reduce surgical blood loss. A recent systematic review6 of randomised controlled trials of anti-fibrinolytic agents (mainly aprotinin or tranexamic acid) in elective surgical patients identified 89 trials including 8,580 randomised patients (74 trials in cardiac, eight in orthopaedic, four in liver, and three in vascular surgery). The results showed that these treatments reduced the numbers needing transfusion by one third, reduced the volume needed per transfusion by one unit, and halved the need for further surgery to control bleeding. These differences were all highly statistically significant. There was also a statistically non-significant reduction in the risk of death (RR=0.85: 95%CI 0.63 to 1.14) in the anti-fibrinolytic treated group. The CRASH 2 trial will be a large international, placebo controlled trial of the effects of the early administration of the anti-fibrinolytic agent tranexamic acid on death, vascular events and transfusion requirements.
Authors and Affiliations
Lan ROBERTS, Tim COATS, Hunt BEVERLY, Shakur HALEEMA
Keywords
Related Articles
- EP ID EP118521
- DOI -
- Views 86
- Downloads 0
Maymun ve Sıçanlarda Orta Serebral Arterin Kapanmasını Takiben İnsülin-Benzeri Büyüme Faktörü-1 Yapımındaki Değişiklikler: cDNA Mikroarray, İmmünohistokimya ve İn Situ Hibridizasyon Çalışmaları
Sıçan ve koyun modelinde serebral iskemi üzerine, insülin benzeri büyüme faktörünün (IGF-1) kuvvetli bir nöroprotektif etkisi olduğu bilinmektedir. İnsanda inme sırasında nöroprotektif bir etki olup olmadığının araştırıl...
Domoik Asit Kaynaklı Hipokampal Dejenerasyonda Nitrik Oksidin Rolü
Nitrik oksidin (NO) antikonvülzan özellikleri olup olmadığını araştırmak üzere domoik asit (DA) ile tetiklenmiş fare temporal lob epilepsi modelini kullandı. NO-sentetaz (NOS) inhibitörlerinin varlığı ve yokluğunda DA’in...
The Evaluation of 371 Cases with Cerebral Palsy Between January 1984 and December 2004
Cerebral palsy is a nonprogressive neuropathological condition which is characterized by abnormal control of posture or motion. It develops secondary to a central nervous system lesion, injury or malformation. In this...
Recurrence of Cystic Part of Cerebellar Hemangioblastoma at Early Postoperative Period and its Spontaneous Resolution: A Pregnant Patient With Serial Magnetic Resonance Imaging Findings
We report a patient with cerebellar hemangioblastoma who was operated during her seventh month of pregnancy. The patient underwent operation during which the mural nodule was removed and cyst aspirated but the cyst wall...
Rombensefalosinapsis: Nadir Bir Serebellar Malformasyon
Amaç: Rombensefalosinapsis, serebellar vermisin agenezisi/hipogenezisi ve serebellar hemisferlerlerin birbirine kaynaması ile karakterize bir malformasyondur. Bugüne kadar elliden az olgu bildirilmiş olup, erişkin olgula...